1. Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial. Issue 2 (13th August 2018) Authors: Mease, Philip J; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Jürgen; Hall, Stephen; Geusens, Piet; Pellet, Pascale; Delicha, Evie Maria; Mpofu, Shephard; Pricop, Luminita Journal: RMD open Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗